While this may represent a safeguard mechanism to prevent memory T cell clones to be reactivated against self- or tumor-derived antigens of low affinity20, this result also suggested that the induction of effective memory CD8+ T cell responses against weak T cell epitopes, requires robust IL-2 signaling. The gene discussed is IL2; the disease is neoplasm.